European Archives - Page 75 of 1095 - European Medical Journal

Overexpression of RAD51 Family Genes Linked to Poorer Breast Cancer Prognosis

Overexpression of RAD51 genes correlates with poorer prognosis in breast cancer, highlighting its potential as a prognostic biomarker and therapeutic target.

Blood Biomarkers Predict COVID-19 Mortality in Patients with Cancer

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

Scientists Identify Gut Microbiome Signatures for NAFLD Diagnosis and Treatment

New research published in has identified highly specific gut microbiome signatures linked to non-alcoholic fatty liver disease (NAFLD).

The Second Brain: Transforming Gut Healing: Part 1

In this episode of the EMJ Podcast, host Jonathan Sackier welcomes Douglas Drossman, a pioneer in disorders of gut–brain interaction.

Latine Patients Face Barriers to Psoriasis Treatment Access

A recent qualitative study has provided valuable insights into the experiences of Latine patients in the US living with moderate to severe psoriasis.

Addressing Congenital Cytomegalovirus

Cytomegalovirus (CMV) can have life-changing consequences of birth defects and developmental disabilities if passed to newborn babies…

Engaging the medical mind: Does interactivity improve recall?

Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical education.

2025 AHA Report: The Latest Global Trends in Heart Disease and Stroke

The 2025 AHA report highlights ongoing disparities in cardiovascular health, urging clinicians to enhance prevention and early intervention efforts.

New Genetic Link to Hereditary Prostate Cancer Identified

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer.

First and only chikungunya vaccine approved in UK

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the MHRA.